Search research articles
Contact Us
Filters
Showing results (861-870 of 949) with videos related to
Page
of 95
Sort By:
Cell Death & Disease
|
July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Tahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease
|
August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Tahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer
Tereza Lanickova, Michal Hensler, Lenka Kasikova, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 30, 2002
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent
Qun Li, Keith W Woods, Akiyo Claiborne, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases
Steve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy
S J O'Connor, K J Barr, L Wang, et al.
BMC Cancer
|
December 13, 2006
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
Helmut Friess, Jan M Langrehr, Helmut Oettle, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 23, 2010
International exercise on 124Sb photon emission intensities determination
M-M Bé, B Chauvenet, M-N Amiot, et al.
Neurology
|
September 29, 2020
Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke
Ondrej Volny, Charlotte Zerna, Ales Tomek, et al.
Journal of Medicinal Chemistry
|
April 24, 2020
Discovery of <i>N</i>-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
George S Sheppard, Le Wang, Steven D Fidanze, et al.
Page
of 95
Search research articles
Search
Showing results (861-870 of 949) with videos related to
Sort By:
Page
of 95
Cell Death & Disease
|
July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Tahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease
|
August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Tahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer
Tereza Lanickova, Michal Hensler, Lenka Kasikova, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 30, 2002
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent
Qun Li, Keith W Woods, Akiyo Claiborne, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases
Steve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacy
S J O'Connor, K J Barr, L Wang, et al.
BMC Cancer
|
December 13, 2006
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
Helmut Friess, Jan M Langrehr, Helmut Oettle, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 23, 2010
International exercise on 124Sb photon emission intensities determination
M-M Bé, B Chauvenet, M-N Amiot, et al.
Neurology
|
September 29, 2020
Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke
Ondrej Volny, Charlotte Zerna, Ales Tomek, et al.
Journal of Medicinal Chemistry
|
April 24, 2020
Discovery of <i>N</i>-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
George S Sheppard, Le Wang, Steven D Fidanze, et al.
Page
of 95